Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
UBS
McKinsey
Baxter
Daiichi Sankyo
Colorcon

Generated: July 23, 2019

DrugPatentWatch Database Preview

Patent: 7,449,192

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,449,192
Title:Use of neurotoxin therapy for treatment of urologic and related disorders related to neurogenic bladder dysfunction
Abstract: The present invention related to methods for treating neurological-urological conditions, including neurogenic bladder dysfunction. This is accomplished by administration of a botulinum toxin into the lower urinary tract of a patient with a neurogenic bladder dysfunction, including the bladder or urinary sphincter and the bladder wall.
Inventor(s): Schmidt; Richard A. (Arvada, CO)
Assignee: The Regents of the University of Colorado (Denver, CO)
Application Number:10/778,924
Patent Claims:see list of patent claims

Details for Patent 7,449,192

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Allergan BOTOX COSMETIC onabotulinumtoxina VIAL; SINGLE-USE 103000 005 1991-12-09 ➤ Sign Up The Regents of the University of Colorado (Denver, CO) ➤ Sign Up RX company
Allergan BOTOX COSMETIC onabotulinumtoxina VIAL; SINGLE-USE 103000 004 1991-12-09 ➤ Sign Up The Regents of the University of Colorado (Denver, CO) ➤ Sign Up RX company
Allergan BOTOX onabotulinumtoxina VIAL; SINGLE-USE 103000 003 1991-12-09 ➤ Sign Up The Regents of the University of Colorado (Denver, CO) ➤ Sign Up RX company
Allergan BOTOX onabotulinumtoxina VIAL; SINGLE-USE 103000 002 1991-12-09 ➤ Sign Up The Regents of the University of Colorado (Denver, CO) ➤ Sign Up RX company
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Julphar
Daiichi Sankyo
QuintilesIMS
Queensland Health
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.